138 results on '"Mulder BJM"'
Search Results
2. Abnormal aortic hemodynamics at predilection sites for dissection in patients with Marfan Syndrome: a 4D flow study
- Author
-
Van Andel, MM, primary, Van Ooij, P, additional, Gottwald, L, additional, De Waard, V, additional, Zwinderman, AH, additional, Mulder, BJM, additional, Nederveen, AJ, additional, and Groenink, M, additional
- Published
- 2021
- Full Text
- View/download PDF
3. Poster Session Saturday 14 December - AM: 14/12/2013, 08: 30–12: 30Location: Poster area
- Author
-
Van Riel, ACMJ, Boerlage - Van Dijk, K, De Bruin - Bon, HACM, Araki, M, Meregalli, PG, Koch, KT, Vis, MM, Mulder, BJM, Baan, J, and Bouma, BJ
- Published
- 2013
4. P372The role of bosentan in fontan patients: increase of cardiac output?
- Author
-
Schuuring, M J, Vis, JC, Bouma, BJ, Van Dijk, APJ, Van Melle, JP, Pieper, PG, Vliegen, HW, Sieswerda, GT, and Mulder, BJM
- Published
- 2011
5. P325Mitral valve pathology in aortic coarctation
- Author
-
Luijendijk, P, De Bruin-Bon, HACM, Zwiers, C, Vriend, JWJ, Van Den Brink, RBA, Mulder, BJM, and Bouma, BJ
- Published
- 2011
6. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect
- Author
-
Yap, S-C, Drenthen, W, Meijboom, FJ, Moons, P, Mulder, BJM, Vliegen, HW, van Dijk, APJ, Jaddoe, VWV, Steegers, EAP, Roos-Hesselink, JW, and Pieper, PG
- Published
- 2009
- Full Text
- View/download PDF
7. Education as important predictor for successful employment in adults with congenital heart disease worldwide
- Author
-
Sluman, MA, Apers, S, Sluiter, JK, Nieuwenhuijsen, K, Moons, P, Luyckx, K, Kovacs, AH, Thomet, C, Budts, W, Enomoto, J, Yang, H-L, Jackson, JL, Khairy, P, Cook, SC, Subramanyan, R, Alday, L, Eriksen, K, Dellborg, M, Berghammer, M, Mattsson, E, Mackie, AS, Menahem, S, Caruana, M, Gosney, K, Soufi, A, Fernandes, SM, White, KS, Callus, E, Kutty, S, Bouma, BJ, Mulder, BJM, Sluman, MA, Apers, S, Sluiter, JK, Nieuwenhuijsen, K, Moons, P, Luyckx, K, Kovacs, AH, Thomet, C, Budts, W, Enomoto, J, Yang, H-L, Jackson, JL, Khairy, P, Cook, SC, Subramanyan, R, Alday, L, Eriksen, K, Dellborg, M, Berghammer, M, Mattsson, E, Mackie, AS, Menahem, S, Caruana, M, Gosney, K, Soufi, A, Fernandes, SM, White, KS, Callus, E, Kutty, S, Bouma, BJ, and Mulder, BJM
- Abstract
BACKGROUND: Conflicting results have been reported regarding employment status and work ability in adults with congenital heart disease (CHD). Since this is an important determinant for quality of life, we assessed this in a large international adult CHD cohort. METHODS: Data from 4028 adults with CHD (53% women) from 15 different countries were collected by a uniform survey in the cross-sectional APPROACH International Study. Predictors for employment and work limitations were studied using general linear mixed models. RESULTS: Median age was 32 years (IQR 25-42) and 94% of patients had at least a high school degree. Overall employment rate was 69%, but varied substantially among countries. Higher education (OR 1.99-3.69) and having a partner (OR 1.72) were associated with more employment; female sex (OR 0.66, worse NYHA functional class (OR 0.67-0.13), and a history of congestive heart failure (OR 0.74) were associated with less employment. Limitations at work were reported in 34% and were associated with female sex (OR 1.36), increasing age (OR 1.03 per year), more severe CHD (OR 1.31-2.10), and a history of congestive heart failure (OR 1.57) or mental disorders (OR 2.26). Only a university degree was associated with fewer limitations at work (OR 0.62). CONCLUSIONS: There are genuine differences in the impact of CHD on employment status in different countries. Although the majority of adult CHD patients are employed, limitations at work are common. Education appears to be the main predictor for successful employment and should therefore be encouraged in patients with CHD.
- Published
- 2019
8. Electrical remodeling after percutaneous atrial septal defect closure in pediatric and adult patients
- Author
-
Kamphuis, VP, Nassif, M, Man, SC, Swenne, CA, Kors, Jan, Vink, AS, ten Harkel, ADJ (Arend), Maan, AC, Mulder, BJM, de Winter, RJ, Blom, NA, Kamphuis, VP, Nassif, M, Man, SC, Swenne, CA, Kors, Jan, Vink, AS, ten Harkel, ADJ (Arend), Maan, AC, Mulder, BJM, de Winter, RJ, and Blom, NA
- Published
- 2019
9. Long-term (>10-year) clinical follow-up after young embolic stroke/TIA of undetermined source
- Author
-
Nassif, M, primary, Annink, ME, additional, Yang, H, additional, Rettig, TCD, additional, Roos, YBWEM, additional, van den Brink, RBA, additional, Tijssen, JGP, additional, Mulder, BJM, additional, de Winter, RJ, additional, and Bouma, BJ, additional
- Published
- 2019
- Full Text
- View/download PDF
10. Atrial septal defect in adults is associated with airway hyperresponsiveness
- Author
-
Nassif, M, van Steenwijk, RP, Hogenhout, JM, Lu, HL, de Bruin-Bon, R, Hirsch, Alexander, Sterk, PJ, Bouma, BJ, Straver, B, Tijssen, JGP, Mulder, BJM, de Winter, RJ, Nassif, M, van Steenwijk, RP, Hogenhout, JM, Lu, HL, de Bruin-Bon, R, Hirsch, Alexander, Sterk, PJ, Bouma, BJ, Straver, B, Tijssen, JGP, Mulder, BJM, and de Winter, RJ
- Published
- 2018
11. Long-term (>10-year) clinical follow-up after young embolic stroke/TIA of undetermined source.
- Author
-
Nassif, M, Annink, ME, Yang, H, Rettig, TCD, Roos, YBWEM, van den Brink, RBA, Tijssen, JGP, Mulder, BJM, de Winter, RJ, and Bouma, BJ
- Subjects
STROKE ,ATRIAL fibrillation ,TRANSIENT ischemic attack - Abstract
Background: To date, the pathophysiology of first-ever and recurrent stroke/TIA still remains unclear in young patients with embolic stroke/TIA of undetermined source (ESUS). Clinical studies with long-term follow-up in young ESUS patients are necessary to investigate the underlying pathophysiology of first-ever and recurrent stroke/TIA in this patient population, in particular the role of new-onset atrial fibrillation. Aims: Our aim was to study the long-term (>10-year) clinical outcome of young patients (<50 years) with ESUS. Methods: This cohort study included all patients aged ≤ 50 years who underwent transoesophageal echocardiography for diagnostic work-up of ESUS during 1996–2008 from one tertiary center. All patients were contacted by telephone between September–November 2018 to update clinical information from medical records. The clinical outcomes of this study were incidence rates of all-cause and cardiovascular mortality, recurrent stroke/TIA, new-onset clinical AF, and ischemic vascular events. Results: In total, 108 patients (57% female, mean age 40 ± 7.2 years [range 19–50 years], n = 72 stroke) were included. Across clinical follow-up (median 13[IQR 10–16] years), 24 patients died (n = 14 cardiovascular). The 15-year incidence rate of recurrent stroke/TIA was 15% (incidence rate = 1.09[95%CI 0.54–1.65]/100 patient-years) and a 5.5% incidence of new-onset clinical AF (incidence rate = 0.44[95%CI 0.09–0.79]/100 patient-years) following ESUS. Conclusions: The incidence of recurrent stroke/TIA is relatively high during long-term clinical follow-up of young patients with ESUS. In contrast, new-onset clinical AF is relatively low and therefore may not play an important part in the pathophysiology of first-ever and recurrent stroke/TIA of these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
12. Uteroplacental Doppler flow and pregnancy outcome in women with tetralogy of Fallot
- Author
-
Kampman, MAM, Siegmund, AS, Bilardo, CM, Veldhuisen, DJ, Balci, A, Oudijk, MA, Groen, H, Mulder, BJM, Roos - Hesselink, Jolien, Sieswerda, G, de Laat, MWM, Sollie-Szarynska, KM, Pieper, PG, Reproductive Origins of Adult Health and Disease (ROAHD), Cardiovascular Centre (CVC), Methods in Medicines evaluation & Outcomes research (M2O), Value, Affordability and Sustainability (VALUE), Amsterdam Reproduction & Development (AR&D), Obstetrics and Gynaecology, Cardiology, APH - Personalized Medicine, APH - Aging & Later Life, and ACS - Heart failure & arrhythmias
- Subjects
CONGENITAL HEART-DISEASE ,PREECLAMPSIA ,COMPLICATIONS ,pregnancy outcome ,CARDIAC-FUNCTION ,BLOOD-FLOW ,UTERINE ARTERY DOPPLER ,REPAIRED TETRALOGY ,utcroplacental Doppler flow ,congenital heart disease ,DYSFUNCTION ,SURGICAL-CORRECTION ,REFERENCE RANGES - Abstract
Pregnancy in women with surgically corrected tetralogy of Fallot (ToF) is associated with cardiac, obstetric and neonatal complications. We compared uteroplacental Doppler flow (UDF) measurements and pregnancy outcome in women with ToF and in healthy women and aimed to assess whether a relationship exists between cardiac function and UDF in women with ToF. We evaluated prospectively pregnant women with ToF and healthy pregnant women from the ZAHARA studies. Clinical evaluation, standardized echocardiography and UDF measurements were performed at 20 and 32 weeks' gestation. We included 62 women with ToF and 69 healthy controls. Cardiac complications, mostly arrhythmia, occurred in 8.1% of women with ToF. There was a higher incidence of small-for-gestational age (21.0% vs 4.4%, P = 0.004) and low birth weight (16.1% vs 2.9%, P = 0.009) in the group of women with ToF than in healthy controls. In women with ToF, early diastolic notching of uterine artery waveform at 20 and 32 weeks occurred more frequently (9.8% vs 1.5%, P = 0.034 and 7.0% vs 0%, P = 0.025, respectively) and the umbilical artery pulsatility index at 32 weeks was higher (1.02 ± 0.20 vs 0.94 ± 0.17, P = 0.015) than in healthy controls. Right ventricular function parameters prepregnancy and at 20 weeks' gestation were significantly associated with abnormal UDF. UDF parameters were associated with adverse neonatal outcome. The majority of women with surgically corrected ToF tolerate pregnancy well. However, UDF indices are more frequently abnormal in these women, suggesting impaired placentation. The association of impaired right ventricular function parameters with abnormal UDF suggests that cardiac dysfunction contributes to defective placentation or placental perfusion mismatch and may explain the increased incidence of obstetric and neonatal complications. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd
- Published
- 2017
13. Aortic microcalcification is associated with elastin fragmentation in Marfan syndrome
- Author
-
Wanga, S, Hibender, S, Ridwan, Yanto, van Roomen, C, Vos, M, van der Made, I, Vliet, N, Franken, R, van Riel, L, Groenink, M, Zwinderman, AH, Mulder, BJM, de Vries, CJM, Essers, J., de Waard, V, Wanga, S, Hibender, S, Ridwan, Yanto, van Roomen, C, Vos, M, van der Made, I, Vliet, N, Franken, R, van Riel, L, Groenink, M, Zwinderman, AH, Mulder, BJM, de Vries, CJM, Essers, J., and de Waard, V
- Published
- 2017
14. Heritable Thoracic Aortic Disorders
- Author
-
Mulder, BJM, De Graaf - van de Laar, Ingrid, Backer, J, Baars, HF, Doevendans, PAFM, Houweling, AC, van Tintelen, JP, and Clinical Genetics
- Published
- 2016
15. Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy?
- Author
-
Grewal, N, Franken, R, Mulder, BJM, Goumans, MJ, Lindeman, JHN, Jongbloed, MRM, DeRuiter, MC, Klautz, RJM, Bogers, Ad, Poelmann, RE, de Groot, AC, Grewal, N, Franken, R, Mulder, BJM, Goumans, MJ, Lindeman, JHN, Jongbloed, MRM, DeRuiter, MC, Klautz, RJM, Bogers, Ad, Poelmann, RE, and de Groot, AC
- Abstract
Patients with bicuspid aortic valve (BAV) and patients with Marfan syndrome (MFS) are more prone to develop aortic dilation and dissection compared to persons with a tricuspid aortic valve (TAV). To elucidate potential common and distinct pathways of clinical relevance, we compared the histopathological substrates of aortopathy. Ascending aortic wall biopsies were divided in five groups: BAV (n = 36) and TAV (n = 23) without and with dilation and non-dilated MFS (n = 8). General histologic features, apoptosis, the expression of markers for vascular smooth muscle cell (VSMC) maturation, markers predictive for ascending aortic dilation in BAV, and expression of fibrillin-1 were investigated. Both MFS and BAV showed an altered distribution and decreased fibrillin-1 expression in the aorta and a significantly lower level of differentiated VSMC markers. Interestingly, markers predictive for aortic dilation in BAV were not expressed in the MFS aorta. The aorta in MFS was similar to the aorta in dilated TAV with regard to the presence of medial degeneration and apoptosis, while other markers for degeneration and aging like inflammation and progerin expression were low in MFS, comparable to BAV. Both MFS and BAV aortas have immature VSMCs, while MFS and TAV patients have a similar increased rate of medial degeneration. However, the mechanism leading to apoptosis is expected to be different, being fibrillin-1 mutation induced increased angiotensin-receptor-pathway signaling in MFS and cardiovascular aging and increased progerin in TAV. Our findings could explain why angiotensin inhibition is successful in MFS and less effective in TAV and BAV patients.
- Published
- 2016
16. Aangeboren hartafwijkingen bij volwassen
- Author
-
Meijboom, FJ (Folkert), Bogers, Ad, Mulder, BJM, Pieper, PG, Meijboom, FJ, Hamer, JPM, Cardiology, and Cardiothoracic Surgery
- Published
- 2013
17. Pregnancy outcome in women with repaired versus unrepaired isolated ventricular septal defect
- Author
-
Yap, Sing, Drenthen, W, Pieper, PG, Moons, P, Mulder, BJM, Vliegen, HW, van Dijk, APJ, Meijboom, FJ (Folkert), Jaddoe, Vincent, Steegers, Eric, Boersma, Eric, Roos - Hesselink, Jolien, Cardiology, Erasmus MC other, and Obstetrics & Gynecology
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities - Abstract
Objective To compare the risks of pregnancy complications in women with repaired and unrepaired isolated ventricular septal defect (VSD). Design A retrospective multicentre study. Setting Tertiary centres in the Netherlands and Belgium. Methods Women were identified using two congenital heart disease registries. Eighty-eight women were identified who had experienced 202 pregnancies, including 46 miscarriages and nine terminations of pregnancy. Information on each completed pregnancy (n = 147; unrepaired VSD, n = 104; repaired VSD, n = 43) was obtained using medical records and telephone interviews. Data from the Generation R database (prospective cohort study; n = 9667) were used to determine the background risk (controls). Odds ratios and 95% CI were estimated using general estimation equation analysis adjusted for multiple pregnancies per woman, maternal age and parity status. Main outcome measures Adjusted odds ratios (AORs) for developing pregnancy complications in relation to corrective status. Results Pregnancies in women with an unrepaired VSD were associated with a higher risk of pre-eclampsia (AOR 4.59, 95% CI 2.01-10.5, P < 0.001) compared with controls. No differences were observed when comparing women with repaired VSD and controls. Pregnancies in women with repaired VSD were associated with a higher risk of premature labour (AOR 4.02, 95% CI 1.12-14.4, P = 0.03) and small-for-gestational-age (SGA) births (AOR 4.09, 95% CI 1.27-13.2, P = 0.02) compared with women with unrepaired VSD. Conclusions Women with unrepaired VSD are at increased risk of pre-eclampsia, which suggests that it is not a benign condition. In addition, women with repaired VSD are at increased risk of premature labour and SGA births compared with women with unrepaired VSD.
- Published
- 2010
18. Ebstein's anomaly may be caused by mutations in the sarcomere protein gene MYH7
- Author
-
Engelen, K, Postma, AV, van de Meerakker, JBA, Roos - Hesselink, Jolien, Helderman-van d Enden, ATJM, Vliegen, HW, Rahman, T, Baars, MJH, Sels, JW, Bauer, U, Pickardt, T, Sperling, SR, Moorman, AFM, Keavney, B, Goodship, J, Klaassen, S, Mulder, BJM, Engelen, K, Postma, AV, van de Meerakker, JBA, Roos - Hesselink, Jolien, Helderman-van d Enden, ATJM, Vliegen, HW, Rahman, T, Baars, MJH, Sels, JW, Bauer, U, Pickardt, T, Sperling, SR, Moorman, AFM, Keavney, B, Goodship, J, Klaassen, S, and Mulder, BJM
- Abstract
Ebstein's anomaly is a rare congenital heart malformation characterised by adherence of the septal and posterior leaflets of the tricuspid valve to the underlying myocardium. Associated abnormalities of left ventricular morphology and function including left ventricular noncompaction (LVNC) have been observed. An association between Ebstein's anomaly with LVNC and mutations in the sarcomeric protein gene MYH7, encoding beta-myosin heavy chain, has been shown by recent studies. This might represent a specific subtype of Ebstein's anomaly with a Mendelian inheritance pattern. In this review we discuss the association of MYH7 mutations with Ebstein's anomaly and LVNC and its implications for the clinical care for patients and their family members.
- Published
- 2013
19. ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters
- Author
-
Neffke, JGJ, Tulevski, I.I., van der Wall, EE, Wilde, AAM, van Veldhuisen, DJ, Dodge-Khatami, A, Mulder, BJM, and Cardiovascular Centre (CVC)
- Subjects
REPAIR ,ARRHYTHMIAS ,POSTOPERATIVE TETRALOGY ,SUDDEN-DEATH ,BRAIN NATRIURETIC PEPTIDE ,MARKER ,SYSTOLIC DYSFUNCTION ,cardiovascular system ,QRS PROLONGATION ,CHILDREN ,cardiovascular diseases ,FALLOT - Abstract
Objective: To examine retrospectively the changes in ECG parameters over time and their correlation with other quantitative right ventricular (RV) function parameters in patients with chronic RV pressure overload caused by congenital heart disease. Methods: 48 patients with chronic RV pressure overload caused by the following congenital heart diseases were studied: nine with congenitally corrected transposition of the great arteries (TGA), 12 with surgically corrected TGA, and 27 with a subpulmonary pressure overloaded RV. QRS duration and dispersion were measured manually from standard ECG recorded twice within five years. RV end diastolic volume (EDV) and RV mass were determined by magnetic resonance imaging. Brain natriuretic peptide (BNP) plasma concentrations were measured. Results: QRS duration and QRS dispersion increased in all patient groups during the follow up period. QRS duration increased significantly in the congenitally corrected TGA (p = 0.04) and the subpulmonary pressure overloaded RV groups (p = 0.01). QRS dispersion increased significantly in patients with surgically corrected TGA (p = 0.03) and in the subpulmonary pressure overloaded RV group (p = 0.02). A significant correlation was found between QRS duration and RVEDV (r = 0.71, p
- Published
- 2002
20. Utility of a BNP as a marker for RV dysfunction in acute pulmonary embolism
- Author
-
Tulevski, I.I., Mulder, BJM, van Veldhuisen, DJ, and Cardiovascular Centre (CVC)
- Subjects
RIGHT-VENTRICULAR DYSFUNCTION ,INCREASED BRAIN - Published
- 2002
21. Quantitative assessment of the pressure and volume overloaded right ventricle: imaging is a real challenge
- Author
-
Tulevski, I.I., Romkes, H, Dodge-Khatami, A, van der Wall, EE, Groenink, M, van Veldhuisen, DJ, Mulder, BJM, Cardiology, Radiology and Nuclear Medicine, and Cardiovascular Centre (CVC)
- Subjects
right ventricular function ,DIASTOLIC FUNCTION ,DOPPLER-ECHOCARDIOGRAPHY ,MUSTARD OPERATION ,CONGENITALLY CORRECTED TRANSPOSITION ,GREAT-ARTERIES ,congenital heart disease imaging ,DOBUTAMINE STRESS ,HEART-DISEASE ,CARDIAC-CATHETERIZATION ,ADULT PATIENTS ,FILLING PRESSURES - Published
- 2002
22. Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women
- Author
-
Tan, ES, van der Meer, J, de Kam, PJ, Dunselman, PHJM, Mulder, BJM, Ascoop, CAPL, Pfisterer, M, and Lie, KI
- Subjects
EVENTS ,SEX-DIFFERENCES ,OCCLUSION ,MYOCARDIAL-INFARCTION ,LONG-TERM ,MAMMARY ARTERY ,MORTALITY ,CASS ,SURVIVAL ,DISEASE - Abstract
OBJECTIVES This retrospective study sought to assess differences in graft patency and clinical outcome between women and men after coronary artery bypass graft surgery (CABG). BACKGROUND A less favorable clinical outcome has been reported in women as compared with men. Its relation to graft patency has not been studied. METHODS We analyzed one-year follow-up data of 912 patients (120 women) who entered a randomized clinical drug trial. All patients received vein grafts; in 494 patients (56 women) internal mammary artery (IMA) grafts were also used. Graft patency was assessed by coronary angiography at one year. Primary clinical end points were myocardial infarction, revascularization procedures and death; secondary clinical end paints included recurrent angina, heart failure and arrhythmias. RESULTS Occlusion rates of vein grafts were 16.7% in women and 12.4% in men (odds ratio [OR] 1.62, 95% confidence interval [CI] 0.88 to 3.00, p = 0.12); occlusion rates of IMA grafts were 3.4% and 5.7% in women and men, respectively (OR 0.56 95% CI 0.08 to 3.96, p = 0.56). Primary clinical end points were observed in 16.7% of women and 9.2% of men (OR 1.97, 95% CI 1.10 to 3.34, p = 0.022), and any clinical end point in 41.7% of women and 25.8% of men (OR 2.06, 95%, CI 1.39 to 3.04, p = 0.0004). Myocardial infarction (15% ts. 7.6%, OR 2.15, 95% CI 1.24 to 3.75, p = 0.013) and recurrent angina (26.7% vs. 15.4%, OR 2.00, 95% CI 1.28 to 3.11, p = 0.004) occurred most frequently. Multivariate regression analysis did not identify gender as an independent risk factor for graft occlusion or the clinical end points. Graft occlusion was an independent predictor of the composite primary clinical end point (OR 2.75, 95% CI 1.59 to 4.75, p = 0.0003) and each of the secondary clinical end points. The observed differences were due to an imbalance of risk factors at baseline and to surgical and graft characteristics. CONCLUSIONS One-year occlusion rates of vein and IMA grafts were comparable in women and men. Clinical outcome was related to Raft patency and was less favorable in women owing to their uneven distribution of risk factors among both groups. (C) 1999 by the American College of Cardiology.
- Published
- 1999
23. Intra-observer and interobserver variability of biventricular function, volumes and mass in patients with congenital heart disease measured by CMR imaging
- Author
-
Luijnenburg, Saskia, Robbers-Visser, D, Moelker, Adriaan, Vliegen, HW, Mulder, BJM, Helbing, W.A., Luijnenburg, Saskia, Robbers-Visser, D, Moelker, Adriaan, Vliegen, HW, Mulder, BJM, and Helbing, W.A.
- Published
- 2010
24. Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity
- Author
-
Winter, MM, Bernink, FJP, Groenink, M, Bouma, BJ, van Dijk, APJ, Helbing, W.A., Adal, Kedir, Mulder, BJM, Winter, MM, Bernink, FJP, Groenink, M, Bouma, BJ, van Dijk, APJ, Helbing, W.A., Adal, Kedir, and Mulder, BJM
- Abstract
Background: The method used to delineate the boundary of the right ventricle (RV), relative to the trabeculations and papillary muscles in cardiovascular magnetic resonance (CMR) ventricular volume analysis, may matter more when these structures are hypertrophied than in individuals with normal cardiovascular anatomy. This study aimed to compare two methods of cavity delineation in patients with systemic RV. Methods: Twenty-nine patients (mean age 34.7 +/- 12.4 years) with a systemic RV (12 with congenitally corrected transposition of the great arteries (ccTGA) and 17 with atrially switched (TGA) underwent CMR. We compared measurements of systemic RV volumes and function using two analysis protocols. The RV trabeculations and papillary muscles were either included in the calculated blood volume, the boundary drawn immediately within the apparently compacted myocardial layer, or they were manually outlined and excluded. RV stroke volume (SV) calculated using each method was compared with corresponding left ventricular (LV) SV. Additionally, we compared the differences in analysis time, and in intra- and inter-observer variability between the two methods. Paired samples t-test was used to test for differences in volumes, function and analysis time between the two methods. Differences in intra- and inter-observer reproducibility were tested using an extension of the Bland-Altman method. Results: The inclusion of trabeculations and papillary muscles in the ventricular volume resulted in higher values for systemic RV end diastolic volume (mean difference 28.7 +/- 10.6 ml, p < 0.001) and for end systolic volume (mean difference 31.0 +/- 11.5 ml, p < 0.001). Values for ejection fraction were significantly lower (mean difference -7.4 +/- 3.9%, p < 0.001) if structures were included. LV SV did not differ significantly from RV SV for both analysis methods (p = NS). Including structures resulted in shorter analysis time (p < 0.001), and showed better inter-observer
- Published
- 2008
25. Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey
- Author
-
Moons, P, Engelfriet, P, Kaemmerer, H, Meijboom, FJ (Folkert), Oechslin, E, Mulder, BJM, Moons, P, Engelfriet, P, Kaemmerer, H, Meijboom, FJ (Folkert), Oechslin, E, and Mulder, BJM
- Published
- 2006
26. Aprotinin in aortocoronary bypass surgery: Increased risk of vein-graft occlusion and myocardial infarction? Supportive evidence from a retrospective study
- Author
-
van der Meer, J, Hillege, HL, Ascoop, CAPL, Dunselman, PHJM, Mulder, BJM, vanOmmen, GVA, Pfisterer, M, vanGilst, WH, and Lie, KI
- Subjects
TRASYLOL ,BLOOD-TRANSFUSION ,REDUCTION ,CARDIOPULMONARY BYPASS ,REQUIREMENT ,HIGH-DOSE APROTININ ,hormones, hormone substitutes, and hormone antagonists ,OPEN-HEART SURGERY - Abstract
To assess the thrombotic risk of aprotinin in aortocoronary bypass surgery, we retrospectively analyzed the results of a trial, originally designed to compare the effects of one-year treatment with various antithrombotic drugs in the prevention of vein-graft occlusion. Graft patency at one year was assessed by angiography. Myocardial infarction, thromboembolism, major bleeding, and death were clinical endpoints. Of 948 randomized patients, 42 received aprotinin, all enrolled by one of the participating centres. Occlusion rates of distal anastomoses were 20.5% in the aprotinin group and 12.7% in the non-aprotinin group (p = 0.091). The proportions of patients with occluded grafts were 44.1% versus 26.3% (p = 0.029). Perioperative myocardial infarction occurred in 14.3% and 7.0%, respectively (p = 0.12). Mean postoperative blood loss was 451 mi in the aprotinin group compared with 1039 mi in the non-aprotinin group (p
- Published
- 1996
27. Aortic root pathology in Marfan syndrome increases the risk of migraine with aura
- Author
-
Koppen, H, primary, Vis, JC, additional, Gooiker, DJ, additional, Knudsen, S, additional, Bouma, BJ, additional, Tijssen, JGP, additional, de Mol, BAJM, additional, Mulder, BJM, additional, Russell, MB, additional, and Ferrari, MD, additional
- Published
- 2012
- Full Text
- View/download PDF
28. Critical appraisal of the revised Ghent criteria for diagnosis of Marfan syndrome
- Author
-
Radonic, T, primary, de Witte, P, additional, Groenink, M, additional, de Bruin-Bon, RACM, additional, Timmermans, J, additional, Scholte, AJH, additional, van den Berg, MP, additional, Baars, MJH, additional, van Tintelen, JP, additional, Kempers, M, additional, Zwinderman, AH, additional, and Mulder, BJM, additional
- Published
- 2011
- Full Text
- View/download PDF
29. A COMPARISON OF INTERNAL MAMMARY ARTERY AND SAPHENOUS-VEIN GRAFTS AFTER CORONARY-ARTERY BYPASS-SURGERY - NO DIFFERENCE IN 1-YEAR OCCLUSION RATES AND CLINICAL OUTCOME
- Author
-
VANDERMEER, J, HILLEGE, HL, VANGILST, WH, DELARIVIERE, AB, DUNSELMAN, PHJM, FIDLER, [No Value], KOOTSTRA, GJ, MULDER, BJM, PFISTERER, M, LIE, KI, MEIJLER, FL, ASCOOP, CAPL, DUNNING, AJ, MICHELS, HR, DEMEDINA, EOR, WELLENS, HJJ, ARNTZENIUS, AC, LUBSEN, J, SCHUILENBERG, RM, SKOTNICKI, SH, DEFEYTER, PJ, HOORNTJE, JCA, VISSER, FC, VANDIJK, RB, DENHEYER, P, JANSSEN, J, VANOMMEN, GVA, BAR, FWHM, HAUER, RNW, VIERSMA, JW, FANGGIDAEJ, D, LIEM, AL, TEUBEN, JHM, VANDERVEEN, HF, TIJSSEN, JGP, VUIJK, M, DEJONGSTE, MJL, EIJGELAAR, A, VANDERDOEF, R, PIEK, J, MEYNE, NG, GIN, RMTY, VERMEULEN, FE, BUSER, P, BURKART, F, GRADEL, E, BONNIER, JJRM, BAVINCK, JH, NUSE, J, SEGGEWISS, K, POSIVAL, H, GLEICHMANN, U, KORFER, R, TERRES, W, BLEIFELD, W, KALMAR, P, PENN, OEK, HITCHCOCK, JF, Wever, E., Life Course Epidemiology (LCE), Cardiovascular Centre (CVC), and Groningen Kidney Center (GKC)
- Subjects
surgical procedures, operative ,BYPASS ,ARTERIES ,PATENCY ,DIPYRIDAMOLE ,LOW-DOSE ASPIRIN ,SURVIVAL ,TRIAL ,VEINS ,CHOICE ,CLINICAL TRIALS ,ORAL ANTICOAGULANTS - Abstract
Background Superior patency rates for internal mammary artery (IMA) grafts compared with vein coronary bypass grafts have been demonstrated by retrospective studies. This difference may have been affected by selection bias of patients and coronary arteries for IMA grafting. Methods and Results To estimate the difference between IMA and vein grafts, we analyzed graft patency data of 912 patients who entered a randomized clinical drug trial. In this trial, 494 patients received both IMA and vein grafts (group 1) and 418 only vein grafts (group 2). Occlusion rates of IMA grafts and IMA plus vein grafts in group 1 were compared with those of vein grafts in group 2. Multivariate analysis was used to compare occlusion rates of IMA and vein grafts while other variables related to graft patency were controlled for. In addition, 1-year clinical outcome was assessed by the incidence of myocardial infarction, thrombosis, major bleeding, and death. Occlusion rates of distal anastomoses in group 1 versus group 2 were 5.4% (IMA grafts) versus 12.7% (vein grafts) (P Conclusions The observed difference in 1-year occlusion rates between IMA and vein grafts can be explained by a maldistribution of graft characteristics by selection of coronary arteries for IMA grafting rather than being ascribed to graft material. One-year clinical outcome is not improved by IMA grafting.
- Published
- 1994
30. EFFECT OF VARIOUS ANTITHROMBOTIC REGIMENS (ASPIRIN, ASPIRIN PLUS DIPYRIDAMOLE, ANTICOAGULANTS) ON THE FUNCTIONAL STATUS OF PATIENTS AND GRAFTS ONE-YEAR AFTER CORONARY-ARTERY BYPASS-GRAFTING
- Author
-
MULDER, BJM, VANDERDOEF, RM, VANDERWALL, EE, TIJSSEN, JGP, PIEK, JJ, VANDERMEER, J, and DUNNING, AJ
- Subjects
CORONARY ARTERY BYPASS SURGERY ,OCCLUSION ,SURGERY ,TL-201 SCINTIGRAPHY ,ANTICOAGULANTS ,PATENCY ,LOW-DOSE ASPIRIN ,EXERCISE ,IMPROVEMENT ,MYOCARDIAL PERFUSION ,EXERCISE PERFORMANCE ,THERAPY ,PREVENTION - Published
- 1994
31. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction
- Author
-
Tulevski, JI, Groenink, M, van der Wall, EE, Veldhuisen, DJ, Boomsma, Frans, Stoker, J, Hirsch, Alexander, Lemkes, JS, Mulder, BJM, Tulevski, JI, Groenink, M, van der Wall, EE, Veldhuisen, DJ, Boomsma, Frans, Stoker, J, Hirsch, Alexander, Lemkes, JS, and Mulder, BJM
- Published
- 2001
32. Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension.
- Author
-
Duffels MGJ, Hardziyenka M, Surie S, de Bruin-Bon RHA, Hoendermis ES, van Dijk APJ, Bouma BJ, Tan HL, Berger RMF, Bresser P, and Mulder BJM
- Published
- 2009
- Full Text
- View/download PDF
33. Heartbeat sensitivity in adults with congenital heart disease.
- Author
-
Rietveld S, Karsdorp PA, and Mulder BJM
- Abstract
This study tested the hypothesis that patients with a congenital heart disease are sensitive regarding heartbeat perception, reflected in enhanced attention for heartbeat, estimation of own heart rate, and a vulnerability to become anxious by listening to heartbeat sounds. Twenty adults with a congenital heart disease, and 20 healthy controls conducted 3 experimental tasks: a concentration task during distraction by heartbeat sounds, own heart rate estimation, and exposure to different patterns of heartbeat sounds. The results showed that patients were more distracted by heartbeat, and were also worse at estimating heart rate than controls. However, heartbeat sounds did not evoke anxiety. In conclusion, patients with a congenital heart disease may differ from controls in heartbeat perception, but there was no support for obsessive monitoring for heartbeat or excessive reactions to heartbeat sounds. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
34. Relation between exercise-induced hypertension and sustained hypertension in adult patients after successful repair of aortic coarctation.
- Author
-
Vriend JWJ, van Montfrans GA, Romkes HH, Vliegen HW, Veen G, Tijssen JGP, Mulder BJM, Vriend, Joris W J, van Montfrans, Gert A, Romkes, Hans H, Vliegen, Hubert W, Veen, Gerrit, Tijssen, Jan G P, and Mulder, Barbara J M
- Published
- 2004
- Full Text
- View/download PDF
35. Abnormalities in liver function and coagulation profile following the Fontan procedure.
- Author
-
van Nieuwenhuizen RC, Peters M, Lubbers LJ, Trip MD, Tijssen JGP, Mulder BJM, van Nieuwenhuizen, R C, Peters, M, Lubbers, L J, Trip, M D, Tijssen, J G, and Mulder, B J
- Abstract
Objective: To investigate liver function and coagulation disorders in patients with a Fontan circulation at different time intervals after surgery.Design: Retrospective analysis of clinical data and cross sectional study relating liver function and coagulation profile to time since surgery, in 28 surviving patients after the modified Fontan procedure.Patients: 20 patients (71%) with atriopulmonary anastomosis, seven (25%) with atrioventricular anastomosis, and one (4%) with total cavopulmonary connection. Follow up ranged from 2.0 to 21.8 years (mean 11.1).Results: Abnormal liver function tests, mainly reflecting cholestasis, were present in 21 patients who had a significantly longer follow up (p < 0.01). Protein synthesis was normal in almost all patients. Coagulation profile showed abnormalities in 22 patients. "Procoagulant" abnormalities-that is, decreased plasminogen and protein C activity-were found in 11 and five patients, respectively. The extent of these abnormalities was less in patients with a longer follow up. Anticoagulant abnormalities were factor V deficiency in 16 patients and factor VII deficiency in 17, resulting in a prolonged prothrombin time in 19 patients. Thirteen patients had both pro- and anticoagulant abnormalities. A prethrombotic state was present in five patients, with a significantly longer mean time interval since surgery (p = 0.05). Thus, although the individual procoagulant indices decreased with increasing time intervals since surgery, a prethrombotic state was found particularly in patients with a long term follow up.Conclusions: Mild cholestasis was mainly present in Fontan patients with a long duration of follow up. Along with laboratory procoagulant abnormalities indicating a prethrombotic state, anticoagulant abnormalities were also present. The coagulation profile varied at different time intervals after surgery. Thus detailed evaluation should be performed regularly, and the use of anticoagulants should be considered in every patient. Long term prospective studies are needed to evaluate the individual fluctuations of coagulation profile over time following a Fontan procedure. [ABSTRACT FROM AUTHOR]- Published
- 1999
36. Valvular heart disease in pregnancy.
- Author
-
Mulder BJM, Bleker OP, Mulder, Barbara J M, and Bleker, Otto P
- Published
- 2003
37. Poster Session Saturday 14 December - AM: 14/12/2013, 08:30-12:30 * Location: Poster area
- Author
-
Muraru, D, Addetia, K, Veronesi, F, Corsi, C, Mor-Avi, V, Yamat, M, Weinert, L, Lang, RM, Badano, LP, Faita, F, Di Lascio, N, Bruno, RM, Bianchini, E, Ghiadoni, L, Sicari, R, Gemignani, V, Angelis, A, Ageli, K, Ioakimidis, N, Chrysohoou, C, Agelakas, A, Felekos, I, Vaina, S, Aznaourides, K, Vlachopoulos, C, Stefanadis, C, Nemes, A, Szolnoky, G, Gavaller, H, Gonczy, A, Kemeny, L, Forster, T, Ramalho, A, Placido, R, Marta, L, Menezes, M, Magalhaes, A, Cortez Dias, N, Martins, S, Almeida, A, Pinto, F, Nunes Diogo, A, Botezatu, C-D, Enache, R, Popescu, BA, Nastase, O, Coman, MC, Ghiorghiu, I, Calin, A, Rosca, M, Beladan, C, Ginghina, C, Grapsa, J, Cabrita, IZ, Durighel, G, Oregan, D, Dawson, D, Nihoyannopoulos, P, Pellicori, P, Kallvikbacka-Bennett, A, Zhang, J, Lukaschuk, E, Joseph, A, Bourantas, C, Loh, H, Bragadeesh, T, Clark, A, Cleland, JG, Kallvikbacka-Bennett, A, Pellicori, P, Lomax, S, Putzu, P, Diercx, R, Parsons, S, Dicken, B, Zhang, J, Clark, A, Cleland, JG, Vered, Z, Adirevitz, L, Dragu, R, Blatt, A, Karev, E, Malca, Y, Roytvarf, A, Marek, D, Sovova, E, Berkova, M, Cihalik, C, Taborsky, M, Lindqvist, P, Tossavainen, ERIK, Soderberg, S, Gonzales, M, Gustavsson, S, Henein, MY, Sonne, C, Bott-Fluegel, L, Hauck, S, Lesevic, H, Hadamitzky, M, Wolf, P, Kolb, C, Bandera, F, Pellegrino, M, Generati, G, Donghi, V, Alfonzetti, E, Castelvecchio, S, Menicanti, L, Guazzi, M, Buchyte, S, Rinkuniene, D, Jurkevicius, R, Smarz, K, Zaborska, B, Jaxa-Chamiec, T, Maciejewski, P, Budaj, A, Santoro, A, Federico Alvino, FA, Giovanni Antonelli, GA, Roberta Molle, RM, Matteo Bertini, MB, Stefano Lunghetti, SL, Sergio Mondillo, SM, Henri, C, Magne, J, Dulgheru, R, Laaraibi, S, Voilliot, D, Kou, S, Pierard, L, Lancellotti, P, Szulik, M, Stabryla-Deska, J, Kalinowski, M, Sliwinska, A, Szymala, M, Lenarczyk, R, Kalarus, Z, Kukulski, T, Investigators, TRUST CRT, Yiangou, K, Azina, C, Yiangou, A, Ioannides, M, Chimonides, S, Baysal, S, Pirat, B, Okyay, K, Bal, U, Muderrisoglu, H, Popovic, D, Ostojic, M, Petrovic, M, Vujisic-Tesic, B, Arandjelovic, A, Petrovic, I, Banovic, M, Popovic, B, Vukcevic, V, Damjanovic, S, Velasco Del Castillo, S, Onaindia Gandarias, JJ, Arana Achaga, X, Laraudogoitia Zaldumbide, E, Rodriguez Sanchez, I, Cacicedo De Bobadilla, A, Romero Pereiro, A, Aguirre Larracoechea, U, Salinas, T, Subinas, A, Elzbieciak, M, Wita, K, Grabka, M, Chmurawa, J, Doruchowska, A, Turski, M, Filipecki, A, Wybraniec, M, Mizia-Stec, K, Varho, VV, Karjalainen, PP, Lehtinen, T, Airaksinen, JKE, Ylitalo, A, Kiviniemi, TO, Gargiulo, P, Galderisi, M, D Amore, C, Lo Iudice, F, Savarese, G, Casaretti, L, Pellegrino, AM, Fabiani, I, La Mura, L, Perrone Filardi, P, Kim, J Y, Chung, WB, Yu, JS, Choi, YS, Park, CS, Youn, HJ, Lee, MY, Nagy, AI, Manouras, A, Gunyeli, E, Gustafsson, U, Shahgaldi, K, Winter, R, Johnsson, J, Zagatina, A, Krylova, L, Zhuravskaya, N, Vareldzyan, Y, Tyurina, TV, Clitsenko, O, Khalifa, E A, Ashour, Z, Elnagar, W, Jung, IH, Seo, HS, Lee, SJ, Lim, DS, Mizariene, V, Verseckaite, R, Janenaite, J, Jonkaitiene, R, Jurkevicius, R, Sanchez Espino, AD, Bonaque Gonzalez, JC, Merchan Ortega, G, Bolivar Herrera, N, Ikuta, I, Macancela Quinones, JJ, Gomez Recio, M, Silva Fazendas Adame, P R, Caldeira, D, Stuart, B, Almeida, S, Cruz, I, Ferreira, A, Freire, G, Lopes, L, Cotrim, C, Pereira, H, Mediratta, A, Addetia, K, Moss, JD, Nayak, HM, Yamat, M, Weinert, L, Mor-Avi, V, Lang, RM, Al Amri, I, Debonnaire, P, Van Der Kley, F, Schalij, MJ, Bax, JJ, Ajmone Marsan, N, Delgado, V, Schmidt, F P, Gniewosz, T, Jabs, A, Munzel, T, Jansen, T, Kaempfner, D, Hink, U, Von Bardeleben, RS, Jose, J, George, OK, Joseph, G, Jose, J, Adawi, S, Najjar, R, Ahronson, D, Shiran, A, Van Riel, ACMJ, Boerlage - Van Dijk, K, De Bruin - Bon, HACM, Araki, M, Meregalli, PG, Koch, KT, Vis, MM, Mulder, BJM, Baan, J, Bouma, BJ, Marciniak, A, Elton, D, Glover, K, Campbell, I, Sharma, R, Batalha, S, Lourenco, C, Oliveira Da Silva, C, Manouras, A, Shahgaldi, K, Caballero, L, Garcia-Lara, J, Gonzalez-Carrillo, J, Oliva, MJ, Saura, D, Garcia-Navarro, M, Espinosa, MD, Pinar, E, Valdes, M, De La Morena, G, Barreiro Perez, M, Lopez Perez, M, Roy, D, Brecker, S, Sharma, R, Venkateshvaran, A, Dash, P K, Sola, S, Barooah, B, Govind, S C, Winter, R, Shahgaldi, K, Brodin, L A, Manouras, A, Saura Espin, D, Caballero Jimenez, L, Gonzalez Carrillo, J, Oliva Sandoval, MJ, Lopez Ruiz, M, Garcia Navarro, M, Espinosa Garcia, MD, Valdes Chavarri, M, De La Morena Valenzuela, G, Gatti, G, Dellangela, L, Pinamonti, B, Benussi, B, Sinagra, G, Pappalardo, A, Group, Heart Muscle Disease Study, Hernandez, V, Saavedra, J, Gonzalez, A, Iglesias, P, Civantos, S, Guijarro, G, Monereo, S, Ikeda, M, Toh, N, Oe, H, Tanabe, Y, Watanabe, N, Ito, H, Ciampi, Q, Cortigiani, L, Pratali, L, Rigo, F, Villari, B, Picano, E, Sicari, R, Yoon, JH, Sohn, JW, Kim, YJ, Chang, HJ, Hong, GR, Kim, TH, Ha, JW, Choi, BW, Rim, SJ, Choi, EY, Tibazarwa, K, Sliwa, K, Wonkam, A, Mayosi, BM, Oryshchyn, N, Ivaniv, Y, Pavlyk, S, Lourenco, M R, Azevedo, O, Moutinho, J, Nogueira, I, Fernandes, M, Pereira, V, Quelhas, I, Lourenco, A, Sunbul, M, Tigen, K, Karaahmet, T, Dundar, C, Ozben, B, Guler, A, Cincin, A, Bulut, M, Sari, I, Basaran, Y, Baydar, O, Kadriye Kilickesmez, KK, Ugur Coskun, UC, Polat Canbolat, PC, Veysel Oktay, VO, Umit Yasar Sinan, US, Okay Abaci, OA, Cuneyt Kocas, CK, Sinan Uner, SU, Serdar Kucukoglu, SK, Zaroui, A, Mourali, MS, Ben Said, R, Asmi, M, Aloui, H, Kaabachi, N, Mechmeche, R, Saberniak, J, Hasselberg, NE, Borgquist, R, Platonov, PG, Holst, AG, Edvardsen, T, Haugaa, KH, Lourenco, M R, Azevedo, O, Nogueira, I, Moutinho, J, Fernandes, M, Pereira, V, Quelhas, I, Lourenco, A, Eran, A, Yueksel, D, Er, F, Gassanov, N, Rosenkranz, S, Baldus, S, Guedelhoefer, H, Faust, M, Caglayan, E, Matveeva, N, Nartsissova, G, Chernjavskij, A, Ippolito, R, De Palma, D, Muscariello, R, Santoro, C, Raia, R, Schiano-Lomoriello, V, Gargiulo, F, Galderisi, M, Lipari, P, Bonapace, S, Zenari, L, Valbusa, F, Rossi, A, Lanzoni, L, Canali, G, Molon, G, Campopiano, E, Barbieri, E, Ikonomidis, I, Varoudi, M, Papadavid, E, Theodoropoulos, K, Papadakis, I, Pavlidis, G, Triantafyllidi, H, Anastasiou - Nana, M, Rigopoulos, D, Lekakis, J, Sunbul, M, Tigen, K, Ozen, G, Durmus, E, Kivrak, T, Cincin, A, Ozben, B, Atas, H, Direskeneli, H, Basaran, Y, Stevanovic, A, Dekleva, M, Trajic, S, Paunovic, N, Simic, A, Khan, SG, Mushemi-Blake, S, Jouhra, F, Dennes, W, Monaghan, M, Melikian, N, Shah, AM, Division, Cardiovascular, Excellence, Kings BHF Centre of, Maceira Gonzalez, A M, Lopez-Lereu, MP, Monmeneu, JV, Igual, B, Estornell, J, Boraita, A, Kosmala, W, Rojek, A, Bialy, D, Mysiak, A, Przewlocka-Kosmala, M, Popescu, I, Mancas, S, Mornos, C, Serbescu, I, Ionescu, G, Ionac, A, Gaudron, P, Niemann, M, Herrmann, S, Hu, K, Liu, D, Wojciech, K, Frantz, S, Bijnens, B, Ertl, G, Weidemann, F, Maceira Gonzalez, A M, Cosin-Sales, J, Ruvira, J, Diago, JL, Aguilar, J, Igual, B, Lopez-Lereu, MP, Monmeneu, J, Estornell, J, Cruz, C, Pinho, T, Madureira, AJ, Lebreiro, A, Dias, CC, Ramos, I, Silva Cardoso, J, Julia Maciel, M, De Meester, P, Van De Bruaene, A, Herijgers, P, Voigt, J-U, Budts, W, Franzoso, F, Voser, EM, Wohlmut, C, Kellenberger, CJ, Valsangiacomo Buechel, E, Carrero, C, Benger, J, Parcerisa, MF, Falconi, M, Oberti, PF, Granja, M, Cagide, AM, Del Pasqua, A, Secinaro, A, Antonelli, G, Iacomino, M, Toscano, A, Chinali, M, Esposito, C, Carotti, A, Pongiglione, G, Rinelli, G, Youssef Moustafa, A, Al Murayeh, M, Al Masswary, A, Al Sheikh, K, Moselhy, M, Dardir, MD, Deising, J, Butz, T, Suermeci, G, Liebeton, J, Wennemann, R, Tzikas, S, Van Bracht, M, Prull, MW, Trappe, H-J, Martin Hidalgo, M, Delgado Ortega, M, Ruiz Ortiz, M, Mesa Rubio, D, Carrasco Avalos, F, Seoane Garcia, T, Pan Alvarez-Ossorio, M, Lopez Aguilera, J, Puentes Chiachio, M, Suarez De Lezo Cruz Conde, J, Petrovic, M T, Giga, V, Stepanovic, J, Tesic, M, Jovanovic, I, Djordjevic-Dikic, A, Generati, G, Pellegrino, M, Bandera, F, Donghi, V, Alfonzetti, E, Guazzi, M, Piatkowski, R, Kochanowski, J, Scislo, P, Opolski, G, Zagatina, A, Zhuravskaya, N, Krylova, L, Vareldzhyan, Y, Tyurina, TV, Clitsenko, O, Bombardini, T, Gherardi, S, Leone, O, Picano, E, Michelotto, E, Ciccarone, A, Tarantino, N, Ostuni, V, Rubino, M, Genco, W, Santoro, G, Carretta, D, Romito, R, Colonna, P, foundation, Cassa di Risparmio di Puglia, Cameli, M, Lunghetti, S, Lisi, M, Curci, V, Cameli, P, Focardi, M, Favilli, R, Galderisi, M, Mondillo, S, Hoffmann, R, Barletta, G, Von Bardeleben, S, Kasprzak, J, Greis, C, Vanoverschelde, J, Becher, H, Machida, T, Izumo, M, Suzuki, K, Kaimijima, R, Mizukoshi, K, Manabe-Uematsu, M, Takai, M, Harada, T, Akashi, YJ, Medicine., St. Marianna University School of, Cardiology, Division of, Martin Garcia, A, Arribas-Jimenez, A, Cruz-Gonzalez, I, Nieto, F, Iscar, A, Merchan, S, Martin-Luengo, C, Brecht, A, Theres, L, Spethmann, S, Dreger, H, Baumann, G, Knebel, F, Jasaityte, R, Heyde, B, Rademakers, F, Claus, P, Dhooge, J, Lervik Nilsen, L C, Lund, J, Brekke, B, Stoylen, A, Giraldeau, G, Duchateau, N, Gabrielli, L, Penela, D, Evertz, R, Mont, L, Brugada, J, Berruezo, A, Bijnens, BH, Sitges, M, Kordybach, M, Kowalski, M, Hoffman, P, Pilichowska, E, Zaborska, B, Baran, J, Kulakowski, P, Budaj, A, Wahi, S, Vollbon, W, Leano, R, Thomas, A, Bricknell, K, Holland, D, Napier, S, Stanton, T, Teferici, D, Qirko, S, Petrela, E, Dibra, A, Bajraktari, G, Bara, P, Sanchis Ruiz, L, Gabrielli, L, Andrea, R, Falces, C, Duchateau, N, Perez-Villa, F, Bijnens, B, Sitges, M, Sulemane, S, Panoulas, VF, Bratsas, AH, Tam, FW, Nihoyannopoulos, P, Abduch, MCD, Alencar, AM, Coracin, FL, Barban, A, Saboya, R, Dulley, FL, Mathias, W, Vieira, MLC, Buccheri, S, Mangiafico, S, Arcidiacono, A, Bottari, VE, Leggio, S, Tamburino, C, Monte, I P, Cruz, C, Lebreiro, A, Pinho, T, Dias, CC, Silva Cardoso, J, Julia Maciel, M, Spitzer, E, Beitzke, D, Kaneider, A, Pavo, N, Gottsauner-Wolf, M, Wolf, F, Loewe, C, Mushtaq, S, Andreini, D, Pontone, G, Bertella, E, Conte, E, Baggiano, A, Annoni, A, Cortinovis, S, Fiorentini, C, Pepi, M, Gustafsson, M, Alehagen, U, Dahlstrom, U, Johansson, P, Faden, G, Faggiano, P, Albertini, L, Reverberi, C, Gaibazzi, N, Taylor, R J, Moody, WE, Umar, F, Edwards, NC, Townend, JN, Steeds, RP, Leyva, F, Mihaila, S, Muraru, D, Piasentini, E, Peluso, D, Casablanca, S, Naso, P, Puma, L, Iliceto, S, Vinereanu, D, Badano, LP, Ciciarello, F L, Agati, L, Cimino, S, De Luca, L, Petronilli, V, Fedele, F, and Tsverava, M
- Abstract
Purpose: Transthoracic 3D echocardiography (3DE) allows an unparalleled opportunity for quantifying the dynamic changes of the tricuspid annulus (TA). Accordingly, our aims were: (I) to assess the determinants of TA size during cardiac cycle in healthy subjects; (II) to propose an approach and timing for TA sizing using 3DE. Methods: In 50 healthy volunteers (45±14 yrs, range 18-74, 27 males, with no risk factors, symptoms, signs or history of cardiovascular disease and on no medication), a full-volume dataset of the right ventricle (RV) containing the tricuspid valve (TV) was acquired (Vivid E9, GE Healthcare). TA diameters (septo-lateral, SL; antero-posterior, AP) and areas were measured on multiplanar images (Flexi-slice, EchoPac BT12, GE Healthcare) at 5 time points during the cardiac cycle: OS (onset of systole, at TV closure); MS (mid-systole); ES (end-systole); ED (onset of diastole); LD (late diastole, after the P wave). RV volumes and ejection fraction (EF) were analyzed with commercial software (4D RV analysis, TomTec, D). Results: Temporal resolution of the 3D datasets was 32±4 vps (range 24-53). TA areas were more closely correlated with RV volumes and body surface area (BSA) than with either SL or AP diameters. TA areas increased during systole from OS (3.9±0.6 cm2/m2) to ES (4.9±0.8 cm2/m2) and reached its largest area in LD (6.7±1.0 cm2/m2). All 5 TA areas were correlated with BSA (r range 0.57-0.62) and RV volumes (r ranges 0.53-0.60 for end-diastolic volume and 0.43-0.50 for end-systolic volume, p<0.0001 for all). Indexed TA areas were not related to either age or gender. With multivariable analysis, both RV end-diastolic volume and BSA determined TA areas during systole and early diastole, while TA area at LD and at OS were independently related with BSA only. Conclusions: In healthy subjects, the main determinants of TA size are RV volume and BSA. The largest TA area occurs at LD and is independently related with BSA only. Therefore, normative values should be based on TA areas measured at LD and indexed for BSA. However, the rapid change in TA areas occurring from LD to OS underscores the importance of adequate temporal resolution of 3DE data sets for reliable TA measurements.
- Published
- 2013
- Full Text
- View/download PDF
38. Relation of physical activity, cardiac function, exercise capacity, and quality of life in patients with a systemic right ventricle.
- Author
-
Winter MM, Bouma BJ, van Dijk AP, Groenink M, Nieuwkerk PT, van der Plas MN, Sieswerda GT, Konings TC, and Mulder BJM
- Published
- 2008
- Full Text
- View/download PDF
39. Aortic root growth in men and women with the Marfan's syndrome.
- Author
-
Meijboom LJ, Timmermans J, Zwinderman AH, Engelfriet PM, Mulder BJM, Meijboom, Lilian J, Timmermans, Janneke, Zwinderman, Aeiko H, Engelfriet, Peter M, and Mulder, Barbara J M
- Abstract
The leading cause of premature death in patients with Marfan's syndrome (MS) is type A aortic dissection or rupture due to progressive aortic root dilation. The aim of this study was to analyze aortic root growth in 113 men and 108 women with MS. All patients were prospectively followed with serial echocardiograms of the native aortic root. At baseline, women had on average a 5-mm smaller aortic root diameter adjusted for age than men. Average aortic root growth was 0.42 mm/year (SE 0.05) in men and 0.38 mm/year (SE 0.04) in women. On the basis of aortic root growth rates, the men and women could be divided into 2 normally distributed subgroups: fast and slow growers. Approximately 1 in 7 men (1.5 mm/year, SE 0.5) and approximately 1 in 9 women (1.8 mm/year, SE 0.3) had fast-growing aortic root diameters. Significantly more type A dissections (25% vs 4%, p <0.001) were observed in fast growers than in slow growers; this was found in men and women. Type A dissections were observed in 4 men and 9 women. By reducing the cut-off value by 5 mm for elective aortic root replacement in women, type A dissections could have been prevented in 3 women. In conclusion, guidelines should take gender differences into account, and therefore, the investigators propose reducing the threshold for elective aortic root replacement in women with MS by 5 mm. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
40. Outcome late after repair of tetralogy of Fallot
- Author
-
Luijnenburg, Saskia, Helbing, W.A., Mulder, BJM, Vliegen, HW, and Pediatrics
- Published
- 2013
41. Improved Risk Prediction Using a Refined European Guidelines Instrument in Pulmonary Arterial Hypertension Related to Congenital Heart Disease.
- Author
-
van Dissel AC, D'Alto M, Farro A, Mathijssen H, Post MC, Bassareo PP, van Dijk APJ, Mulder BJM, and Bouma BJ
- Abstract
The European guidelines advocate a goal-oriented treatment approach in pulmonary arterial hypertension (PAH), based on a comprehensive risk assessment instrument, which has been validated in several PAH subgroups. We investigated its discriminatory ability and explored tricuspid annular plane systolic excursion and revised thresholds to improve its predictability within the adult congenital heart disease (CHD) population. In total, 223 adults (42 ± 16 years, 66% women, 68% Eisenmenger) were enrolled from 5 European PAH-CHD expert centers. Patients were classified as low, intermediate, or high risk at the baseline visit and at follow-up within 4 to 18 months. By the general PAH guidelines instrument, survival did not differ between the risk groups (p-value not significant), mostly because of the skewed group distribution. Reclassifying patients using revised thresholds for N-terminal pro-brain natriuretic peptide and 6-minute walk distance (i.e., low, intermediate, and high as <500, 500 to 1,400, >1,400 ng/L and >400, and 165 to 400 and <165 m, respectively) and use of tricuspid annular plane systolic excursion (low, intermediate, and high as >20, 16 to 20, and <16 mm, respectively) significantly improved the discrimination between the risk groups at baseline and follow-up (p = 0.001, receiver operating characteristic increase from 0.648 to 0.701), reclassifying 64 patients (29%). Irrespective of follow-up risk group, survival was better for patients with higher proportions of low-risk variables. Improvement to a low-risk profile at a median of 9 months of follow-up provided improved survival compared with the survival of patients who remained in the low-risk group. In conclusion, the external validity of general risk instrument for PAH appeared to be of limited discriminatory value in patients with PAH-CHD. We propose a refined risk instrument with improved discrimination for PAH-CHD., Competing Interests: Declaration of competing interest Dr. Bouma reports financial support was provided by Janssen-Cilag. The remaining authors have no competing interests to declare., (Copyright © 2024. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
42. Decreased clinical performance in TGA-ASO patients after RVOT interventions; a multicenter European collaboration.
- Author
-
Engele LJ, González-Fernández V, Mulder BJM, Ruperti-Repilado FJ, Abia RL, van der Vlist K, Buendía F, Rueda J, Gabriel H, Schrutka L, Bouchardy J, Schwerzmann M, Possner M, Greutmann M, Gallego P, Ladouceur M, Jongbloed MRM, Tobler D, Dos L, and Bouma BJ
- Subjects
- Humans, Male, Female, Adult, Young Adult, Europe epidemiology, Ventricular Outflow Obstruction surgery, Ventricular Outflow Obstruction physiopathology, Ventricular Outflow Obstruction diagnostic imaging, Arterial Switch Operation methods, Arterial Switch Operation adverse effects, Exercise Tolerance physiology, Exercise Test methods, Treatment Outcome, Ventricular Function, Right physiology, Follow-Up Studies, Transposition of Great Vessels surgery, Transposition of Great Vessels physiopathology
- Abstract
Background: In patients with transposition of the great arteries and an arterial switch operation (TGA-ASO) right ventricular outflow tract (RVOT) obstruction is a common complication requiring one or more RVOT interventions., Objectives: We aimed to assess cardiopulmonary exercise capacity and right ventricular function in patients stratified for type of RVOT intervention., Methods: TGA-ASO patients (≥16 years) were stratified by type of RVOT intervention. The following outcome parameters were included: predicted (%) peak oxygen uptake (peak VO2), tricuspid annular plane systolic excursion (TAPSE), tricuspid Lateral Annular Systolic Velocity (TV S'), right ventricle (RV)-arterial coupling (defined as TAPSE/RV systolic pressure ratio), and N-terminal proBNP (NT-proBNP)., Results: 447 TGA patients with a mean age of 25.0 (interquartile range (IQR) 21-29) years were included. Patients without previous RVOT intervention (n = 338, 76%) had a significantly higher predicted peak VO2 (78.0 ± 17.4%) compared to patients with single approach catheter-based RVOT intervention (73.7 ± 12.7%), single approach surgical RVOT intervention (73.8 ± 28.1%), and patients with multiple approach RVOT intervention (66.2 ± 14.0%, p = 0.021). RV-arterial coupling was found to be significantly lower in patients with prior catheter-based and/or surgical RVOT intervention compared to patients without any RVOT intervention (p = 0.029)., Conclusions: TGA patients after a successful arterial switch repair have a decreased exercise capacity. A considerable amount of TGA patients with either catheter or surgical RVOT intervention perform significantly worse compared to patients without RVOT interventions., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
43. Clinical Course of TGA After Arterial Switch Operation in the Current Era.
- Author
-
Engele LJ, van der Palen RLF, Joosen RS, Sieswerda GT, Schoof PH, van Melle JP, Berger RMF, Accord RE, Rammeloo LAJ, Konings TC, Helbing WA, Roos-Hesselink JW, van de Woestijne PC, Frerich S, van Dijk APJ, Kuipers IM, Hazekamp MGH, Mulder BJM, Breur JMPJ, Blom N, Jongbloed MRM, and Bouma BJ
- Abstract
Background: The number of patients with an arterial switch operation (ASO) for transposition of the great arteries (TGA) is steadily growing; limited information is available regarding the clinical course in the current era., Objectives: The purpose was to describe clinical outcome late after ASO in a national cohort, including survival, rates of (re-)interventions, and clinical events., Methods: A total of 1,061 TGA-ASO patients (median age 10.7 years [IQR: 2.0-18.2 years]) from a nationwide prospective registry with a median follow-up of 8.0 years (IQR: 5.4-8.8 years) were included. Using an analysis with age as the primary time scale, cumulative incidence of survival, (re)interventions, and clinical events were determined., Results: At the age of 35 years, late survival was 93% (95% CI: 88%-98%). The cumulative re-intervention rate at the right ventricular outflow tract and pulmonary branches was 36% (95% CI: 31%-41%). Other cumulative re-intervention rates at 35 years were on the left ventricular outflow tract (neo-aortic root and valve) 16% (95% CI: 10%-22%), aortic arch 9% (95% CI: 5%-13%), and coronary arteries 3% (95% CI: 1%-6%). Furthermore, 11% (95% CI: 6%-16%) of the patients required electrophysiological interventions. Clinical events, including heart failure, endocarditis, and myocardial infarction occurred in 8% (95% CI: 5%-11%). Independent risk factors for any (re-)intervention were TGA morphological subtype (Taussig-Bing double outlet right ventricle [HR: 4.9, 95% CI: 2.9-8.1]) and previous pulmonary artery banding (HR: 1.6, 95% CI: 1.0-2.2)., Conclusions: TGA-ASO patients have an excellent survival. However, their clinical course is characterized by an ongoing need for (re-)interventions, especially on the right ventricular outflow tract and the left ventricular outflow tract indicating a strict lifelong surveillance, also in adulthood., Competing Interests: Support was received from the Netherlands Cardiovascular Research lnitiative: An initiative with support of the Dutch Heart Foundation and Hartekind, CVON2019-002 OUTREACH. The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (© 2024 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
44. Improved Outcomes After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot.
- Author
-
Bokma JP, Geva T, Sleeper LA, Lee JH, Lu M, Sompolinsky T, Babu-Narayan SV, Wald RM, Mulder BJM, and Valente AM
- Subjects
- Humans, Adolescent, Young Adult, Adult, Propensity Score, Registries, Pulmonary Valve surgery, Tetralogy of Fallot surgery, Cardiac Surgical Procedures, Tachycardia, Ventricular epidemiology, Tachycardia, Ventricular etiology, Tachycardia, Ventricular surgery
- Abstract
Background: The impact of pulmonary valve replacement (PVR) on major adverse clinical outcomes in patients with repaired tetralogy of Fallot (rTOF) is unknown., Objectives: The purpose of this study was to determine whether PVR is associated with improved survival and freedom from sustained ventricular tachycardia (VT) in rTOF., Methods: A PVR propensity score was created to adjust for baseline differences between PVR and non-PVR patients enrolled in INDICATOR (International Multicenter TOF Registry). The primary outcome was time to the earliest occurrence of death or sustained VT. PVR and non-PVR patients were matched 1:1 on PVR propensity score (matched cohort) and in the full cohort, modeling was performed with propensity score as a covariate adjustment., Results: Among 1,143 patients with rTOF (age 27 ± 14 years, 47% PVR, follow-up 8.3 ± 5.2 years), the primary outcome occurred in 82. The adjusted HR for the primary outcome for PVR vs no-PVR (matched cohort n = 524) was 0.41 (95% CI: 0.21-0.81; multivariable model P = 0.010). Full cohort analysis revealed similar results. Subgroup analysis suggested beneficial effects in patients with advanced right ventricular (RV) dilatation (interaction P = 0.046; full cohort). In patients with RV end-systolic volume index >80 mL/m
2 , PVR was associated with a lower primary outcome risk (HR: 0.32; 95% CI: 0.16-0.62; P < 0.001). There was no association between PVR and the primary outcome in patients with RV end-systolic volume index ≤80 mL/m2 (HR: 0.86; 95% CI: 0.38-1.92; P = 0.70)., Conclusions: Compared with rTOF patients who did not receive PVR, propensity score-matched individuals receiving PVR had lower risk of a composite endpoint of death or sustained VT., Competing Interests: Funding Support and Author Disclosures This work was supported in part by National Institutes of Health/NLHBI/CCHMC 2UO1HL098147-12 and the Alexander S. Nadas Chair at Harvard Medical School (to Dr Geva), the Lerner Research Award and the Sarah Marie Liamos Fund (to Dr Valente), British Heart Foundation EX/18/1/34296 (to Dr Babu-Narayan), the Canadian Institutes of Health Research MOP 119353 (to Dr Wald), and by the Amsterdam Cardiovascular Sciences (to Dr Bokma). The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
45. Cardiac Fibrosis and Innervation State in Uncorrected and Corrected Transposition of the Great Arteries: A Postmortem Histological Analysis and Systematic Review.
- Author
-
Engele LJ, van der Palen RLF, Egorova AD, Bartelings MM, Wisse LJ, Glashan CA, Kiès P, Vliegen HW, Hazekamp MG, Mulder BJM, Ruiter MC, Bouma BJ, and Jongbloed MRM
- Abstract
In the transposition of the great arteries (TGA), alterations in hemodynamics and oxygen saturation could result in fibrotic remodeling, but histological studies are scarce. We aimed to investigate fibrosis and innervation state in the full spectrum of TGA and correlate findings to clinical literature. Twenty-two human postmortem TGA hearts, including TGA without surgical correction (n = 8), after Mustard/Senning (n = 6), and arterial switch operation (ASO, n = 8), were studied. In newborn uncorrected TGA specimens (1 day-1.5 months), significantly more interstitial fibrosis (8.6% ± 3.0) was observed compared to control hearts (5.4% ± 0.8, p = 0.016). After the Mustard/Senning procedure, the amount of interstitial fibrosis was significantly higher (19.8% ± 5.1, p = 0.002), remarkably more in the subpulmonary left ventricle (LV) than in the systemic right ventricle (RV). In TGA-ASO, an increased amount of fibrosis was found in one adult specimen. The amount of innervation was diminished from 3 days after ASO (0.034% ± 0.017) compared to uncorrected TGA (0.082% ± 0.026, p = 0.036). In conclusion, in these selected postmortem TGA specimens, diffuse interstitial fibrosis was already present in newborn hearts, suggesting that altered oxygen saturations may already impact myocardial structure in the fetal phase. TGA-Mustard/Senning specimens showed diffuse myocardial fibrosis in the systemic RV and, remarkably, in the LV. Post-ASO, decreased uptake of nerve staining was observed, implicating (partial) myocardial denervation after ASO.
- Published
- 2023
- Full Text
- View/download PDF
46. Common genetic variants improve risk stratification after the atrial switch operation for transposition of the great arteries.
- Author
-
Woudstra OI, Skoric-Milosavljevic D, Mulder BJM, Meijboom FJ, Post MC, Jongbloed MRM, van Dijk APJ, van Melle JP, Konings TC, Postma AV, Bezzina CR, Bouma BJ, and Tanck MWT
- Subjects
- Adult, Humans, Genome-Wide Association Study, Follow-Up Studies, Arteries, Risk Assessment, Disease Progression, Retrospective Studies, Arterial Switch Operation adverse effects, Transposition of Great Vessels genetics, Transposition of Great Vessels surgery, Transposition of Great Vessels complications
- Abstract
Background: Clinical factors are used to estimate late complication risk in adults after atrial switch operation (AtrSO) for transposition of the great arteries (TGA), but heterogeneity in clinical course remains. We studied whether common genetic variants are associated with outcome and add value to a clinical risk score in TGA-AtrSO patients., Methods and Results: This multicenter study followed 133 TGA-AtrSO patients (aged 28 [IQR 24-35] years) for 13 (IQR 9-16) years and examined the association of genome-wide single-nucleotide polymorphisms (SNPs) with a composite endpoint of symptomatic ventricular arrhythmia, heart failure hospitalization, ventricular assist device implantation, heart transplantation, or mortality. Thirty-two patients (24%) reached the endpoint. The genome-wide association study yielded one genome-wide significant (p < 1 × 10
-8 ) locus and 18 suggestive loci (p < 1 × 10-5 ). A genetic risk score constructed on the basis of independent SNPs with p < 1 × 10-5 was associated with outcome after correction for the clinical risk score (HR = 1.26/point increase [95%CI 1.17-1.35]). Risk stratification improved with a combined risk score (clinical score + genetic score) compared to the clinical score alone (p = 2 × 10-16 , C-statistic 0.95 vs 0.85). In 51 patients with a clinical intermediate (5-20%) 5-year risk of events, the combined score reclassified 32 patients to low (<5%) and 5 to high (>20%) risk. Stratified by the combined score, observed 5-year event-free survival was 100%, 79% and 31% for low, intermediate, and high-risk patients, respectively., Conclusions: Common genetic variants may explain some variation in the clinical course in TGA-AtrSO and improve risk stratification over clinical factors alone, especially in patients at intermediate clinical risk. These findings support the hypothesis that including genetic variants in risk assessment may be beneficial., Competing Interests: Declaration of Competing Interest None., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
47. A cross-sectional study on fatigue, anxiety, and symptoms of depression and their relation with medical status in adult patients with Marfan syndrome. Psychological consequences in Marfan syndrome.
- Author
-
van Andel MM, Graaumans K, Groenink M, Zwinderman AH, van Kimmenade RRJ, Scholte AJHA, van den Berg MP, Dickinson MG, Knoop H, Bosch JA, Mulder BJM, de Waard V, and Bennebroek Evertsz' F
- Subjects
- Anxiety epidemiology, Anxiety etiology, Anxiety psychology, Cross-Sectional Studies, Depression epidemiology, Depression etiology, Depression psychology, Fatigue complications, Fatigue etiology, Humans, Chronic Pain, Marfan Syndrome complications, Marfan Syndrome diagnosis, Marfan Syndrome epidemiology
- Abstract
Marfan syndrome (MFS) is a connective tissue disorder affecting the cardiovascular, ocular, and skeletal system, which may be accompanied by psychological features. This study aimed to determine the prevalence of fatigue, anxiety, and symptoms of depression in MFS patients, and to assess the degree to which sociodemographic and clinical variables are associated with fatigue and psychological aspects. The prevalence of fatigue, anxiety, and symptoms of depression were assessed in two cohorts of MFS patients and compared with healthy controls. The checklist individual strength (CIS), and hospital anxiety and depression scale (HADS) questionnaires were utilized. Medical status was assessed (family history of MFS, aortic root dilatation >40 mm, previous aortic surgery, aortic dissection, chronic pain, skeletal involvement, and scoliosis). Severe fatigue was experienced by 37% of the total MFS cohort (n = 155). MFS patients scored significantly higher on the CIS questionnaire, concerning severe fatigue, as compared with the general Dutch population (p < 0.0001). There were no differences in HADS anxiety or depression scores. In older MFS patients, with a more severe cardiovascular phenotype, chronic pain, and a higher unemployment rate, significantly more symptoms of depression were observed, when compared with the general population (p = 0.027) or compared with younger MFS patients (p = 0.026). Multivariate analysis, showed that anxiety was associated with chronic pain (p = 0.022) and symptoms of depression with unemployment (p = 0.024). MFS patients report significantly more severe fatigue as compared with the general population. Since the cause of fatigue is unclear, more research may be needed. Psychological intervention, for example, cognitive behavioral therapy, may contribute to a reduction in psychological symptoms., (© 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
48. A bnormal aortic hemodynamics are associated with risk factors for aortic complications in patients with marfan syndrome.
- Author
-
van Andel MM, van Ooij P, de Waard V, Gottwald LM, van Kimmenade RRJ, Scholte AJ, Dickinson MG, Zwinderman AH, Mulder BJM, Nederveen AJ, and Groenink M
- Abstract
Background: It is difficult to assess the risk for aortic dissection beyond the aortic root in patients with Marfan syndrome (MFS). To aid risk assessment in these patients, we investigated aortic flow and wall shear stress (WSS) by 4D flow magnetic resonance imaging (MRI) in patients with MFS and compared the results with healthy volunteers. We hypothesized that MFS patients with a high-risk profile for aortic dissection would show abnormal hemodynamics in aortic regions associated with aortic dissection., Methods: MFS patients (n = 55) and healthy subjects (n = 25), matched for age and sex, prospectively underwent 4D flow MRI. 4D flow maps were constructed to detect elevated (defined as higher than the three-dimensional 95 % confidence interval) and deviant directed (defined as vector angle differences higher than 120°) WSS in MFS patients as compared to the controls. Univariate and multivariate associations with risk factors for aortic dissection in MFS patients were assessed., Results: The maximum incidence for elevated WSS was 20 % (CI 9 %-31 %) and found in the ascending aorta. The maximum for deviant directed WSS was 39 % (CI 26 %-52 %) and found in the inner descending aorta. Significantly more male patients had deviant directed WSS in the inner proximal descending aorta (63 % vs 24 %, p = 0.014). Multivariate analysis showed that deviant directed WSS was associated with male sex (p = 0.019), and a haplo-insufficient FBN1 mutation type (p = 0.040). In 60 % of MFS patients with a previous aortic root replacement surgery, abnormal hemodynamics were found in the ascending aorta. No significant differences between hemodynamics were found in the descending aorta between operated and non-operated patients., Conclusion: Deviant directed WSS in the proximal descending aorta is associated with known risk factors for aortic dissection in MFS patients, namely male sex and a haploinsufficient FBN1 mutation type., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
49. Coagulation and Anticoagulation in Fontan Patients.
- Author
-
Heidendael JF, Engele LJ, Bouma BJ, Dipchand AI, Thorne SA, McCrindle BW, and Mulder BJM
- Subjects
- Adult, Anticoagulants therapeutic use, Child, Humans, Warfarin therapeutic use, Fontan Procedure adverse effects, Fontan Procedure methods, Heart Defects, Congenital epidemiology, Heart Defects, Congenital surgery, Stroke etiology, Venous Thromboembolism drug therapy
- Abstract
Patients with a Fontan circulation for single-ventricle physiology are at increased risk of developing thromboembolic events. Thromboembolic events can lead to failure of the Fontan circulation, chronic sequelae in case of stroke, and early mortality. Controversies exist regarding the substrates, risk factors, and optimal detection methods for thromboembolic events. Despite the major clinical implications, there is currently no consensus regarding the optimal antithrombotic therapy to prevent or treat thromboembolic events after the Fontan procedure. In this review we aimed to untangle the available literature regarding antithrombotic prophylaxis and treatment for pediatric and adult Fontan patients. A decision-tree algorithm for thromboprophylaxis in Fontan patients is proposed. Additionally, the current state of knowledge is reviewed with respect to the epidemiology, pathophysiology, and detection of thromboembolic events in Fontan patients, and important evidence gaps are highlighted., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
50. Hypertensive response to exercise in adult patients with repaired aortic coarctation.
- Author
-
Meijs TA, Muller SA, Minderhoud SCS, de Winter RJ, Mulder BJM, van Melle JP, Hoendermis ES, van Dijk APJ, Zuithoff NPA, Krings GJ, Doevendans PA, Spiering W, Witsenburg M, Roos-Hesselink JW, van den Bosch AE, Bouma BJ, and Voskuil M
- Subjects
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Young Adult, Blood Pressure, Exercise Test methods, Prospective Studies, Aortic Coarctation complications, Aortic Coarctation surgery, Bicuspid Aortic Valve Disease, Hypertension epidemiology, Hypertension etiology
- Abstract
Objective: The clinical and prognostic implications of a hypertensive response to exercise after repair of coarctation of the aorta (CoA) remain controversial. We aimed to determine the prevalence of a hypertensive response to exercise, identify factors associated with peak exercise systolic blood pressure (SBP) and explore the association of peak exercise SBP with resting blood pressure and cardiovascular events during follow-up., Methods: From the Dutch national CONgenital CORvitia (CONCOR) registry, adults with repaired CoA who underwent exercise stress testing were included. A hypertensive response to exercise was defined as a peak exercise SBP ≥210 mm Hg in men and ≥190 mm Hg in women. Cardiovascular events consisted of coronary artery disease, stroke, aortic complications and cardiovascular death., Results: Of the original cohort of 920 adults with repaired CoA, 675 patients (median age 24 years (range 16-72 years)) underwent exercise stress testing. Of these, 299 patients (44%) had a hypertensive response to exercise. Mean follow-up duration was 10.1 years. Male sex, absence of a bicuspid aortic valve and elevated resting SBP were independently associated with increased peak exercise SBP. Peak exercise SBP was positively predictive of office SBP (β=0.11, p<0.001) and 24-hour SBP (β=0.05, p=0.03) at follow-up, despite correction for baseline SBP. During follow-up, 100 patients (15%) developed at least 1 cardiovascular event. Peak exercise SBP was not significantly associated with the occurrence of cardiovascular events (HR 0.994 (95% CI 0.987 to 1.001), p=0.11)., Conclusions: A hypertensive response to exercise was present in nearly half of the patients in this large, prospective cohort of adults with repaired CoA. Risk factors for increased peak exercise SBP were male sex, absence of a bicuspid aortic valve and elevated resting SBP. Increased peak exercise SBP independently predicted hypertension at follow-up. These results support close follow-up of patients with a hypertensive response to exercise to ensure timely diagnosis and treatment of future hypertension., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.